Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Is the oral cavity relevant in SARS-CoV-2 pandemic?
David Herrera, Jorge Serrano, Silvia Roldán, et al.
Clinical Oral Investigations (2020) Vol. 24, Iss. 8, pp. 2925-2930
Open Access | Times Cited: 209

Showing 1-25 of 209 citing articles:

Association between periodontitis and severity of COVID‐19 infection: A case–control study
Nadya Marouf, Wenji Cai, Khalid N. Said, et al.
Journal Of Clinical Periodontology (2021) Vol. 48, Iss. 4, pp. 483-491
Open Access | Times Cited: 323
Hesperidin and SARS-CoV-2: New Light on the Healthy Function of Citrus Fruits
Paolo Bellavite, Alberto Donzelli
Antioxidants (2020) Vol. 9, Iss. 8, pp. 742-742
Open Access | Times Cited: 183
Antiviral Activity of Reagents in Mouth Rinses against SARS-CoV-2
Florence Carrouel, Lúcio Souza Gonçalves, Maria Pia Conte, et al.
Journal of Dental Research (2020) Vol. 100, Iss. 2, pp. 124-132
Open Access | Times Cited: 158
Oral Microbiome Dysbiosis Is Associated With Symptoms Severity and Local Immune/Inflammatory Response in COVID-19 Patients: A Cross-Sectional Study
Irene Soffritti, Maria D’Accolti, Chiara Fabbri, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 118
A prospective clinical pilot study on the effects of a hydrogen peroxide mouthrinse on the intraoral viral load of SARS-CoV-2
Maximilian Josef Gottsauner, Ioannis Michaelides, Bárbara Schmidt, et al.
Clinical Oral Investigations (2020) Vol. 24, Iss. 10, pp. 3707-3713
Open Access | Times Cited: 108
Covid‐19 and oral diseases: Crosstalk, synergy or association?
Daniela Atili Brandini, Aline Satie Takamiya, Pari Thakkar, et al.
Reviews in Medical Virology (2021) Vol. 31, Iss. 6
Open Access | Times Cited: 95
SARS-CoV-2 and Oral Manifestation: An Observational, Human Study
Bruna Sinjari, Damiano D’Ardes, Manlio Santilli, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 10, pp. 3218-3218
Open Access | Times Cited: 87
Oral Manifestations in Patients with COVID-19: A 6-Month Update
Juliana Amorim dos Santos, Ana Gabriela Costa Normando, R.L. Carvalho da Silva, et al.
Journal of Dental Research (2021) Vol. 100, Iss. 12, pp. 1321-1329
Open Access | Times Cited: 83
In vivo evaluation of the virucidal efficacy of chlorhexidine and povidone-iodine mouthwashes against salivary SARS-CoV-2. A randomized-controlled clinical trial
Rola Elzein, Fadi Abdel‐Sater, Soha Fakhreddine, et al.
Journal of Evidence Based Dental Practice (2021) Vol. 21, Iss. 3, pp. 101584-101584
Open Access | Times Cited: 81
Profiling of Oral Microbiota and Cytokines in COVID-19 Patients
Valerio Iebba, Nunzia Zanotta, Giuseppina Campisciano, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 67
Oral Symptoms Associated with COVID-19 and Their Pathogenic Mechanisms: A Literature Review
Hironori Tsuchiya
Dentistry Journal (2021) Vol. 9, Iss. 3, pp. 32-32
Open Access | Times Cited: 66
Virucidal activity of oral care products against SARS-CoV-2 in vitro
Akihiko Komine, Erika Yamaguchi, Nako Okamoto, et al.
Journal of Oral and Maxillofacial Surgery Medicine and Pathology (2021) Vol. 33, Iss. 4, pp. 475-477
Open Access | Times Cited: 63
Oral antiseptics against coronavirus: in-vitro and clinical evidence
María‐Victoria Mateos‐Moreno, Álex Mira, Verónica Ausina-Márquez, et al.
Journal of Hospital Infection (2021) Vol. 113, pp. 30-43
Open Access | Times Cited: 61
Clinical evaluation of antiseptic mouth rinses to reduce salivary load of SARS-CoV-2
María D. Ferrer, Álvaro Sánchez Barrueco, Yolanda Martínez Beneyto, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 55
Periodontitis and COVID-19: Biological Mechanisms and Meta-analyses of Epidemiological Evidence
Giacomo Baima, Crystal Marruganti, Mariano Sanz, et al.
Journal of Dental Research (2022) Vol. 101, Iss. 12, pp. 1430-1440
Closed Access | Times Cited: 46
Periodontitis and coronavirus disease 2019
Faleh Tamimi, Shiraz Altigani, Mariano Sanz
Periodontology 2000 (2022) Vol. 89, Iss. 1, pp. 207-214
Open Access | Times Cited: 38
Your health is in your mouth: A comprehensive view to promote general wellness
Antonia Barranca-Enríquez, Tania Romo‐González
Frontiers in Oral Health (2022) Vol. 3
Open Access | Times Cited: 37
Preprocedural mouthwashes for infection control in dentistry—an update
Johanna Weber, Eva L. Bonn, David L. Auer, et al.
Clinical Oral Investigations (2023) Vol. 27, Iss. S1, pp. 33-44
Open Access | Times Cited: 22
Mouthwash Effects on the Oral Microbiome: Are They Good, Bad, or Balanced?
Zoë Brookes, Leanne Teoh, Fabian Cieplik, et al.
International Dental Journal (2023) Vol. 73, pp. S74-S81
Open Access | Times Cited: 21
The role of viruses in oral mucosal lesions
Henrik Dommisch, Andrea Maria Schmidt‐Westhausen
Periodontology 2000 (2024) Vol. 96, Iss. 1, pp. 189-202
Closed Access | Times Cited: 7
Oral Mucosa, Saliva, and COVID-19 Infection in Oral Health Care
Devi Sewvandini Atukorala Atukorallaya, Ravindra Kumar Ratnayake
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 47
SARS-CoV-2 Infection and Oral Health: Therapeutic Opportunities and Challenges
Christopher J. Coke, Brandon Davison, Niariah Fields, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 1, pp. 156-156
Open Access | Times Cited: 45
Dental biofilm of symptomatic COVID‐19 patients harbours SARS‐CoV‐2
Sabrina Carvalho Gomes, Sabrina Fachin, Juliane Gonçalves da Fonseca, et al.
Journal Of Clinical Periodontology (2021) Vol. 48, Iss. 7, pp. 880-885
Open Access | Times Cited: 44
SARS-CoV-2 Disease Adjuvant Therapies and Supplements Breakthrough for the Infection Prevention
Alessio Danilo Inchingolo, Angelo Michele Inchingolo, Ioana Roxana Bordea, et al.
Microorganisms (2021) Vol. 9, Iss. 3, pp. 525-525
Open Access | Times Cited: 43
Inactivation of SARS-CoV-2 through Treatment with the Mouth Rinsing Solutions ViruProX® and BacterX® Pro
Julia Koch-Heier, Helen Hoffmann, Michael Schindler, et al.
Microorganisms (2021) Vol. 9, Iss. 3, pp. 521-521
Open Access | Times Cited: 42
Page 1 - Next Page

Scroll to top